Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma.
Casales E, Martisova E, Villanueva H, de Cerio ALD, Inoges S, Silva-Pilipich N, Ballesteros-Briones MC, Aranda A, Bezunartea J, Bendandi M, Pastor F, Smerdou C. Casales E, et al. Among authors: bendandi m. Sci Rep. 2021 Nov 2;11(1):21427. doi: 10.1038/s41598-021-00787-5. Sci Rep. 2021. PMID: 34728659 Free PMC article.
Idiotype vaccines for lymphoma therapy.
Inogés S, de Cerio AL, Villanueva H, Soria E, Pastor F, Bendandi M. Inogés S, et al. Among authors: bendandi m. Expert Rev Vaccines. 2011 Jun;10(6):801-9. doi: 10.1586/erv.11.44. Expert Rev Vaccines. 2011. PMID: 21692701 Review.
Idiotype vaccine production using hybridoma technology.
Inoges S, de Cerio AL, Villanueva H, Pastor F, Bendandi M. Inoges S, et al. Among authors: bendandi m. Methods Mol Biol. 2014;1139:367-87. doi: 10.1007/978-1-4939-0345-0_30. Methods Mol Biol. 2014. PMID: 24619694
Idiotype vaccines for human B-cell malignancies.
Inoges S, de Cerio AL, Soria E, Villanueva H, Pastor F, Bendandi M. Inoges S, et al. Among authors: bendandi m. Curr Pharm Des. 2010 Jan;16(3):300-7. doi: 10.2174/138161210790170111. Curr Pharm Des. 2010. PMID: 20109139 Free article. Review.
Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma.
Inogès S, Rodrìguez-Calvillo M, Zabalegui N, Lòpez-Dìaz de Cerio A, Villanueva H, Soria E, Suárez L, Rodríguez-Caballero A, Pastor F, García-Muñóz R, Panizo C, Pèrez-Calvo J, Melero I, Rocha E, Orfao A, Bendandi M; Grupo Español de Linfomas/Trasplante Autologo de Medula Oseo study group; Programa para el Estudio y Tratamiento de Hemopatias Malignas study group. Inogès S, et al. Among authors: bendandi m. J Natl Cancer Inst. 2006 Sep 20;98(18):1292-301. doi: 10.1093/jnci/djj358. J Natl Cancer Inst. 2006. PMID: 16985248 Clinical Trial.
Prolonged idiotypic vaccination against follicular lymphoma.
Inoges S, Lopez-Diaz de Cerio A, Zabalegui N, Soria E, Villanueva H, Panizo C, Rodriguez-Caballero A, Suarez L, Pastor F, Rodriguez-Calvillo M, Orfao A, Bendandi M. Inoges S, et al. Among authors: bendandi m. Leuk Lymphoma. 2009 Jan;50(1):47-53. doi: 10.1080/10428190802601122. Leuk Lymphoma. 2009. PMID: 19152172 Free article.
Stem cell transplant and idiotypic vaccination for B-cell malignancies.
Inoges S, Lopez-Diaz de Cerio A, Sampol A, Nieto J, Soria E, Villanueva H, Pastor F, Bendandi M. Inoges S, et al. Among authors: bendandi m. Curr Top Med Chem. 2011;11(13):1653-60. doi: 10.2174/156802611796117676. Curr Top Med Chem. 2011. PMID: 21446912 Free article. Review.
128 results